Empowering Early Intervention: Navigating Treatments for Delaying T1D Progression, Insights from Pediatric Endocrinology of North Texas - Episode 9

Expert Opinions into the Range of Teplizumab Infusion Locations, Insurance Coverage Hurdles, and the Approval Process

August 2, 2024

Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, Amy Burton, MD, Kathryn Springfield, PA-C, Deborah Shenkman, RDLD, CDCES

Focusing on logistical matters as it pertains to teplizumab administration, the panel discusses infusion site considerations, insurance coverage hurdles, and the process of getting patients approved.

EP. 1: Navigating T1D: Mitigating Burden and Monitoring Disease Progression

EP. 2: T1D Staging: The Clinical Importance of Early Recognition

EP. 3: Engaging the Audience: Polling on Primary Populations and Community Perspectives in T1D Care

EP. 4: T1D Antibody Screening: Identifying High-Risk Populations

EP. 5: Role of Teplizumab: First Approved Treatment for Delaying T1D Stage Progression

EP. 6: TN-10 Study Analysis: Expert Perspectives on Key Efficacy and Safety Data

EP. 7: Exploring Screening and Real-World Use of Teplizumab: Practical Insights and Clinical Experiences

EP. 8: Teplizumab Infusion Protocol: Details on the 14-Day Process and Comprehensive Monitoring Overview

Now Viewing

EP. 9: Expert Opinions into the Range of Teplizumab Infusion Locations, Insurance Coverage Hurdles, and the Approval Process

EP. 10: Final Thoughts on Strategies for Managing and Monitoring Patients Receiving Teplizumab